Title |
A team effort: natural killer cells on the first leg of the tumor immunity relay race
|
---|---|
Published in |
Journal for Immunotherapy of Cancer, July 2018
|
DOI | 10.1186/s40425-018-0380-4 |
Pubmed ID | |
Authors |
Timothy B. Fessenden, Ellen Duong, Stefani Spranger |
Abstract |
Recent work by Böttcher and colleagues defines a new role for Natural Killer cells in the anti-tumor immune response, arriving early into the tumor microenvironment before passing the baton to DC1 dendritic cells. DC1 dendritic cells subsequently activate CD8+ T cells resulting in effective anti-tumor immunity. This work highlights the cooperative nature of anti-tumor immunity set in motion by Natural Killer cells, and immune evasion by tumors through their exclusion. |
X Demographics
The data shown below were collected from the profiles of 26 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 12 | 46% |
Japan | 1 | 4% |
Italy | 1 | 4% |
Unknown | 12 | 46% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 17 | 65% |
Scientists | 4 | 15% |
Practitioners (doctors, other healthcare professionals) | 3 | 12% |
Science communicators (journalists, bloggers, editors) | 2 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 39 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 11 | 28% |
Student > Ph. D. Student | 9 | 23% |
Student > Bachelor | 3 | 8% |
Student > Postgraduate | 2 | 5% |
Student > Master | 2 | 5% |
Other | 1 | 3% |
Unknown | 11 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 9 | 23% |
Immunology and Microbiology | 7 | 18% |
Agricultural and Biological Sciences | 2 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
Medicine and Dentistry | 2 | 5% |
Other | 6 | 15% |
Unknown | 11 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 December 2021.
All research outputs
#2,158,562
of 25,385,509 outputs
Outputs from Journal for Immunotherapy of Cancer
#569
of 3,422 outputs
Outputs of similar age
#43,188
of 339,673 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#15
of 41 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,422 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 339,673 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.